[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2013MU03668A - - Google Patents

Info

Publication number
IN2013MU03668A
IN2013MU03668A IN3668MU2013A IN2013MU03668A IN 2013MU03668 A IN2013MU03668 A IN 2013MU03668A IN 3668MU2013 A IN3668MU2013 A IN 3668MU2013A IN 2013MU03668 A IN2013MU03668 A IN 2013MU03668A
Authority
IN
India
Prior art keywords
composition
relates
budesonide
salts
solid oral
Prior art date
Application number
Other languages
English (en)
Inventor
Ajmal Shareef
Ananda Haranath Uppala
Rahul Sudhakar Dabre
Girish Kumar Jain
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/065914 priority Critical patent/WO2015071812A1/en
Priority to IN3668MU2013 priority patent/IN2013MU03668A/en
Publication of IN2013MU03668A publication Critical patent/IN2013MU03668A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3668MU2013 2013-11-18 2014-11-10 IN2013MU03668A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/065914 WO2015071812A1 (en) 2013-11-18 2014-11-10 Solid oral modified-release composition comprising budesonide or salt thereof
IN3668MU2013 IN2013MU03668A (es) 2013-11-21 2014-11-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3668MU2013 IN2013MU03668A (es) 2013-11-21 2014-11-10

Publications (1)

Publication Number Publication Date
IN2013MU03668A true IN2013MU03668A (es) 2015-07-31

Family

ID=54397632

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3668MU2013 IN2013MU03668A (es) 2013-11-18 2014-11-10

Country Status (1)

Country Link
IN (1) IN2013MU03668A (es)

Similar Documents

Publication Publication Date Title
ZA201708692B (en) Antibacterial compounds
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
MY187540A (en) Compounds active towards bromodomains
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
CL2014001865A1 (es) Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer.
CL2015002897A1 (es) Inhibidores de bace1
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
BR112014030406A8 (pt) combinação de canabidiol fitocanabinoide com hipotermia terapêutica, e, uso de uma combinação
MX2017015293A (es) Composicion para tratar lesiones tisulares.
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
CL2017000884A1 (es) Composición farmacéutica para usarse en el tratamiento o la prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugía de derivación gástrica
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
NZ713440A (en) Nsaid administration and related compositions, methods and systems.
GB2527233A (en) Composition comprising hydrocortisone
IN2013MU02576A (es)
IN2013MU03668A (es)
IN2013MU03612A (es)
IN2013MU03667A (es)
IN2013MU03611A (es)
CL2016000542A1 (es) Composición que comprende hidroxipropil quitosano junto con excipientes y/o adyuvantes farmacéuticamente aceptables; útil en el tratamiento de la onicomicosis.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
IN2013MU03855A (es)